centrosomal localisation Search Results


95
Cytoskeleton Inc centrosomal cytoskeleton apoptotic microtubules 439 localisation
Centrosomal Cytoskeleton Apoptotic Microtubules 439 Localisation, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/centrosomal cytoskeleton apoptotic microtubules 439 localisation/product/Cytoskeleton Inc
Average 95 stars, based on 1 article reviews
centrosomal cytoskeleton apoptotic microtubules 439 localisation - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

99
Oxford Instruments centrosome
Centrosome, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/centrosome/product/Oxford Instruments
Average 99 stars, based on 1 article reviews
centrosome - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

90
DeLaval Inc ift88 proteins
Ift88 Proteins, supplied by DeLaval Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ift88 proteins/product/DeLaval Inc
Average 90 stars, based on 1 article reviews
ift88 proteins - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
Bio-Rad rabbit anti drosophila g tubulin antibody
Rabbit Anti Drosophila G Tubulin Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti drosophila g tubulin antibody/product/Bio-Rad
Average 94 stars, based on 1 article reviews
rabbit anti drosophila g tubulin antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
Evident Corporation bx-51 fluorescence microscope
Bx 51 Fluorescence Microscope, supplied by Evident Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bx-51 fluorescence microscope/product/Evident Corporation
Average 90 stars, based on 1 article reviews
bx-51 fluorescence microscope - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Addgene inc plasmid plvx egfp c1 centrin 1
KEY RESOURCES TABLE
Plasmid Plvx Egfp C1 Centrin 1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid plvx egfp c1 centrin 1/product/Addgene inc
Average 90 stars, based on 1 article reviews
plasmid plvx egfp c1 centrin 1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Tamai Kasei Co Ltd apical cell cortex
KEY RESOURCES TABLE
Apical Cell Cortex, supplied by Tamai Kasei Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apical cell cortex/product/Tamai Kasei Co Ltd
Average 90 stars, based on 1 article reviews
apical cell cortex - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Human Protein Atlas c21orf33/gatd3a
KEY RESOURCES TABLE
C21orf33/Gatd3a, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c21orf33/gatd3a/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
c21orf33/gatd3a - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

93
Addgene inc centrosomal localisation
(A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 115: siControl, 124: siBora, 117: siCep192, 122: siCenexin, 132: siCep192 + siCenexin and 125: Plk1i cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing <t>centrosomal</t> Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 183: siControl, 183: siBora, 181: siCep192, 183: siCenexin, 185: siCep192 + siCenexin and 192: Plk1i cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.
Centrosomal Localisation, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/centrosomal localisation/product/Addgene inc
Average 93 stars, based on 1 article reviews
centrosomal localisation - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Portland Press Ltd gst glutathione 276
(A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 115: siControl, 124: siBora, 117: siCep192, 122: siCenexin, 132: siCep192 + siCenexin and 125: Plk1i cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing <t>centrosomal</t> Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 183: siControl, 183: siBora, 181: siCep192, 183: siCenexin, 185: siCep192 + siCenexin and 192: Plk1i cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.
Gst Glutathione 276, supplied by Portland Press Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gst glutathione 276/product/Portland Press Ltd
Average 90 stars, based on 1 article reviews
gst glutathione 276 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Kosan Biosciences geldanamycin derivatives 17-aag
(A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 115: siControl, 124: siBora, 117: siCep192, 122: siCenexin, 132: siCep192 + siCenexin and 125: Plk1i cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing <t>centrosomal</t> Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 183: siControl, 183: siBora, 181: siCep192, 183: siCenexin, 185: siCep192 + siCenexin and 192: Plk1i cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.
Geldanamycin Derivatives 17 Aag, supplied by Kosan Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/geldanamycin derivatives 17-aag/product/Kosan Biosciences
Average 90 stars, based on 1 article reviews
geldanamycin derivatives 17-aag - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Verlag GmbH akap 450
(A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 115: siControl, 124: siBora, 117: siCep192, 122: siCenexin, 132: siCep192 + siCenexin and 125: Plk1i cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing <t>centrosomal</t> Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 183: siControl, 183: siBora, 181: siCep192, 183: siCenexin, 185: siCep192 + siCenexin and 192: Plk1i cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.
Akap 450, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/akap 450/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
akap 450 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


KEY RESOURCES TABLE

Journal: Cell systems

Article Title: VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells

doi: 10.1016/j.cels.2019.05.009

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Centrosomes were localized by transduction of cells with the plasmid pLVX-eGFP-C1-centrin-1 (Addgene #73331) and subsequent staining for GFP.

Techniques: Recombinant, Protease Inhibitor, Transfection, Expressing, Negative Control, Software, CRISPR

(A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 115: siControl, 124: siBora, 117: siCep192, 122: siCenexin, 132: siCep192 + siCenexin and 125: Plk1i cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing centrosomal Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 183: siControl, 183: siBora, 181: siCep192, 183: siCenexin, 185: siCep192 + siCenexin and 192: Plk1i cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.

Journal: bioRxiv

Article Title: Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions

doi: 10.1101/2025.09.30.679461

Figure Lengend Snippet: (A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 115: siControl, 124: siBora, 117: siCep192, 122: siCenexin, 132: siCep192 + siCenexin and 125: Plk1i cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing centrosomal Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 183: siControl, 183: siBora, 181: siCep192, 183: siCenexin, 185: siCep192 + siCenexin and 192: Plk1i cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.

Article Snippet: These cells were later transfected again with either Plk1-FRET sensor c-jun substrate plasmid (Addgene Plasmid # 45203) or c-jun based Plk1 FRET sensor tagged to PACT domain at c-terminus enabling centrosomal localisation (Addgene Plasmid # Plasmid #106907) using X-tremeGENETM 9 (Merck: XTG9-RO) transfection reagent according to manufacturer’s instructions.

Techniques: Expressing, Activity Assay, Whisker Assay, Derivative Assay

(A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 120: siBora + siCep192, 135: siBora + siCenexin, 127: siBora + siCep192 + siCenexin, 124: siAurora and 121: siPlk1 cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing centrosomal Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 181: siBora + siCep192, 187: siBora + siCenexin, 181: siBora + siCep192 + siCenexin, 182: siAurora and 182: siPlk1 cells. (E-G) Western Blot confirming the depletion of indicated proteins after indicated siRNA treatments. Data represent the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.

Journal: bioRxiv

Article Title: Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions

doi: 10.1101/2025.09.30.679461

Figure Lengend Snippet: (A) Representative images of G2 phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs. (B) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from G2 phase cells represented in (A) derived from N=3 independent experiments comprising n= 120: siBora + siCep192, 135: siBora + siCenexin, 127: siBora + siCep192 + siCenexin, 124: siAurora and 121: siPlk1 cells. (C) Representative images of G2 phase hTERT-RPE1 cells expressing centrosomal Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (D) Box and Whisker plot for FRET measurement-based quantification of centrosomal Plk1 activity calculated from G2 phase cells represented in (C) derived from N=4 independent experiments comprising n= 181: siBora + siCep192, 187: siBora + siCenexin, 181: siBora + siCep192 + siCenexin, 182: siAurora and 182: siPlk1 cells. (E-G) Western Blot confirming the depletion of indicated proteins after indicated siRNA treatments. Data represent the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars = 5 µm.

Article Snippet: These cells were later transfected again with either Plk1-FRET sensor c-jun substrate plasmid (Addgene Plasmid # 45203) or c-jun based Plk1 FRET sensor tagged to PACT domain at c-terminus enabling centrosomal localisation (Addgene Plasmid # Plasmid #106907) using X-tremeGENETM 9 (Merck: XTG9-RO) transfection reagent according to manufacturer’s instructions.

Techniques: Expressing, Activity Assay, Whisker Assay, Derivative Assay, Western Blot

(A-C) Flow cytometry-based quantification of cell cycle profile of hTERT-RPE1 (WT), hTERT-RPE1: Usp28 - / - and hTERT-RPE1: Usp28 - / - 0:0 cells revealing percentage of cells in G1 (A) , S (B) and G2 (C) phases derived from N=4 independent experiments with each treatment comprising around 30,000 cells. (D) Flow cytometry-based quantification of cell cycle profile or RPE1 cells treated with Control vs Cep192 siRNA showing percentage of cells in G1, S and G2 phases obtained from N=5 independent experiments with each treatment comprising of 30,000 cells. (E) Representative images of S phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (F) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from S phase cells represented in (E) derived from N=4 independent experiments comprising n= 203: siControl, 204: siBora, 215: siCep192, 219: siCenexin, 215: Plk1i cells. The leftmost G2 Phase – siControl bar shown is replica of siControl data shown in for side-by-side comparison purposes. G) Representative images of S phase hTERT-RPE1 cells expressing centrosomal Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (H) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from S phase cells represented in (G) derived from N=3 independent experiments comprising n= 163: siControl, 187: siBora, 187: siCep192, 184: siCenexin, 178: Plk1i cells. The leftmost G2 Phase – siControl bar shown is replica of siControl data shown in for side-by-side comparison purposes. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars, Images: 5 µm and zoomed insets: 0.5 µm.

Journal: bioRxiv

Article Title: Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions

doi: 10.1101/2025.09.30.679461

Figure Lengend Snippet: (A-C) Flow cytometry-based quantification of cell cycle profile of hTERT-RPE1 (WT), hTERT-RPE1: Usp28 - / - and hTERT-RPE1: Usp28 - / - 0:0 cells revealing percentage of cells in G1 (A) , S (B) and G2 (C) phases derived from N=4 independent experiments with each treatment comprising around 30,000 cells. (D) Flow cytometry-based quantification of cell cycle profile or RPE1 cells treated with Control vs Cep192 siRNA showing percentage of cells in G1, S and G2 phases obtained from N=5 independent experiments with each treatment comprising of 30,000 cells. (E) Representative images of S phase hTERT-RPE1 cells expressing cellular Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (F) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from S phase cells represented in (E) derived from N=4 independent experiments comprising n= 203: siControl, 204: siBora, 215: siCep192, 219: siCenexin, 215: Plk1i cells. The leftmost G2 Phase – siControl bar shown is replica of siControl data shown in for side-by-side comparison purposes. G) Representative images of S phase hTERT-RPE1 cells expressing centrosomal Plk1 activity sensor and Cyclin A2-mScarlet treated with indicated siRNAs or inhibitors. (H) Box and Whisker plot for FRET measurement-based quantification of cellular Plk1 activity calculated from S phase cells represented in (G) derived from N=3 independent experiments comprising n= 163: siControl, 187: siBora, 187: siCep192, 184: siCenexin, 178: Plk1i cells. The leftmost G2 Phase – siControl bar shown is replica of siControl data shown in for side-by-side comparison purposes. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars, Images: 5 µm and zoomed insets: 0.5 µm.

Article Snippet: These cells were later transfected again with either Plk1-FRET sensor c-jun substrate plasmid (Addgene Plasmid # 45203) or c-jun based Plk1 FRET sensor tagged to PACT domain at c-terminus enabling centrosomal localisation (Addgene Plasmid # Plasmid #106907) using X-tremeGENETM 9 (Merck: XTG9-RO) transfection reagent according to manufacturer’s instructions.

Techniques: Flow Cytometry, Derivative Assay, Control, Expressing, Activity Assay, Whisker Assay, Comparison

(A) Representative images of G2 phase centrosomes stained with γ-tubulin (red) and Pericentrin (green) in hTERT-RPE1 cells treated with indicated siRNA combinations. (B-C) Box and Whisker plots representing the centrosomal levels of γ-tubulin (B) and Pericentrin (C) in cells represented in (A) as derived from N=3 independent experiments consisting of n= (138: siBora + siCep192, 164: siCep192 + siCenexin, 181: siCenexin + siBora and 167: siBora + siCep192 + siCenexin for γ-tubulin) and (n= 136: siBora + siCep192, 167: siCep192 + siCenexin, 181: siCenexin + siBora and 170: siBora + siCep192 + siCenexin for Pericentrin (green) cells. Data presented as the entire range with values between the first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars: 0.5 µm.

Journal: bioRxiv

Article Title: Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions

doi: 10.1101/2025.09.30.679461

Figure Lengend Snippet: (A) Representative images of G2 phase centrosomes stained with γ-tubulin (red) and Pericentrin (green) in hTERT-RPE1 cells treated with indicated siRNA combinations. (B-C) Box and Whisker plots representing the centrosomal levels of γ-tubulin (B) and Pericentrin (C) in cells represented in (A) as derived from N=3 independent experiments consisting of n= (138: siBora + siCep192, 164: siCep192 + siCenexin, 181: siCenexin + siBora and 167: siBora + siCep192 + siCenexin for γ-tubulin) and (n= 136: siBora + siCep192, 167: siCep192 + siCenexin, 181: siCenexin + siBora and 170: siBora + siCep192 + siCenexin for Pericentrin (green) cells. Data presented as the entire range with values between the first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars: 0.5 µm.

Article Snippet: These cells were later transfected again with either Plk1-FRET sensor c-jun substrate plasmid (Addgene Plasmid # 45203) or c-jun based Plk1 FRET sensor tagged to PACT domain at c-terminus enabling centrosomal localisation (Addgene Plasmid # Plasmid #106907) using X-tremeGENETM 9 (Merck: XTG9-RO) transfection reagent according to manufacturer’s instructions.

Techniques: Staining, Whisker Assay, Derivative Assay

(A) Representative images of G2 phase centrosomes stained with γ-tubulin (red) and Pericentrin (green) in hTERT-RPE1 cells treated with indicated siRNAs. (B-C) Box and Whisker plots representing the centrosomal levels of γ-tubulin (B) and Pericentrin (C) in cells represented in (A) as derived from N=3 independent experiments consisting of n= (168: siControl, 171: siBora, 177: siCep192, 165: siCenexin and 168: siPlk1 for γ-tubulin) and (n= 176: siControl, 170: siBora, 179: siCep192, 157: siCenexin and 183: siPlk1 for Pericentrin (green) cells. Data presented as the entire range with values between the first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars: 0.5 µm.

Journal: bioRxiv

Article Title: Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions

doi: 10.1101/2025.09.30.679461

Figure Lengend Snippet: (A) Representative images of G2 phase centrosomes stained with γ-tubulin (red) and Pericentrin (green) in hTERT-RPE1 cells treated with indicated siRNAs. (B-C) Box and Whisker plots representing the centrosomal levels of γ-tubulin (B) and Pericentrin (C) in cells represented in (A) as derived from N=3 independent experiments consisting of n= (168: siControl, 171: siBora, 177: siCep192, 165: siCenexin and 168: siPlk1 for γ-tubulin) and (n= 176: siControl, 170: siBora, 179: siCep192, 157: siCenexin and 183: siPlk1 for Pericentrin (green) cells. Data presented as the entire range with values between the first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars: 0.5 µm.

Article Snippet: These cells were later transfected again with either Plk1-FRET sensor c-jun substrate plasmid (Addgene Plasmid # 45203) or c-jun based Plk1 FRET sensor tagged to PACT domain at c-terminus enabling centrosomal localisation (Addgene Plasmid # Plasmid #106907) using X-tremeGENETM 9 (Merck: XTG9-RO) transfection reagent according to manufacturer’s instructions.

Techniques: Staining, Whisker Assay, Derivative Assay

(A) Expansion microscopy images of centrioles in G2 phase hTERT-RPE1 (WT) and hTERT-RPE1 Cenexin - / - cells stained against α-tubulin and treated with indicated siRNAs to visualise centriole configuration. The arrowheads indicate the disengaged mother daughter centriole pairs. (B) Quantification of percentage of G2 phase hTERT-RPE1 cells with disengaged centrioles in their centrosomes ( N = 3 independent experiments, n = 96, 98, 100 and 104 cells in siControl, siBora, siCep192 and siBora + siCep192, respectively) (C) Quantification of percentage of G2 phase hTERT-RPE1 Cenexin - / - cells with disengaged centrioles in their centrosomes ( N = 5 independent experiments, n = 166, 149, 138 and 145 cells in siControl, siBora, siCep192 and siBora + siCep192, respectively) (D) Representative images of hTERT-RPE1: Centrosomal Separase activity sensor cells depicting centrosomal intensity of GFP and mCherry after indicated siRNA/drug treatments. (E) Box and Whisker plot for quantification of centrosomal activity of Separase in conditions depicted in (D) and derived from N=3 independent experiments consisting of n=142: siControl, 144: siBora, 134: siCep192, 152: siCenexin, 152: siSeparase and 147: Aphidicolin treated cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars: 0.5 µm.

Journal: bioRxiv

Article Title: Bora, CEP192 and Cenexin activate different Plk1 pools and regulate distinct cell and centrosome cycle transitions

doi: 10.1101/2025.09.30.679461

Figure Lengend Snippet: (A) Expansion microscopy images of centrioles in G2 phase hTERT-RPE1 (WT) and hTERT-RPE1 Cenexin - / - cells stained against α-tubulin and treated with indicated siRNAs to visualise centriole configuration. The arrowheads indicate the disengaged mother daughter centriole pairs. (B) Quantification of percentage of G2 phase hTERT-RPE1 cells with disengaged centrioles in their centrosomes ( N = 3 independent experiments, n = 96, 98, 100 and 104 cells in siControl, siBora, siCep192 and siBora + siCep192, respectively) (C) Quantification of percentage of G2 phase hTERT-RPE1 Cenexin - / - cells with disengaged centrioles in their centrosomes ( N = 5 independent experiments, n = 166, 149, 138 and 145 cells in siControl, siBora, siCep192 and siBora + siCep192, respectively) (D) Representative images of hTERT-RPE1: Centrosomal Separase activity sensor cells depicting centrosomal intensity of GFP and mCherry after indicated siRNA/drug treatments. (E) Box and Whisker plot for quantification of centrosomal activity of Separase in conditions depicted in (D) and derived from N=3 independent experiments consisting of n=142: siControl, 144: siBora, 134: siCep192, 152: siCenexin, 152: siSeparase and 147: Aphidicolin treated cells. Data presented as the entire range with values between first and third quartiles in boxes. ‘ + ’ sign in each column represent the mean value (p values for individual comparisons indicated on graphs: Kruskal-Wallis test). Scale bars: 0.5 µm.

Article Snippet: These cells were later transfected again with either Plk1-FRET sensor c-jun substrate plasmid (Addgene Plasmid # 45203) or c-jun based Plk1 FRET sensor tagged to PACT domain at c-terminus enabling centrosomal localisation (Addgene Plasmid # Plasmid #106907) using X-tremeGENETM 9 (Merck: XTG9-RO) transfection reagent according to manufacturer’s instructions.

Techniques: Microscopy, Staining, Activity Assay, Whisker Assay, Derivative Assay